Fingerprint
Dive into the research topics where Jan Beumer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase 1 study of orally administered 5-fluoro-2’-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors
Chen, A. P., Kummar, S., Rubinstein, L., Zlott, J., Coyne, G. O., Chung, V., Newman, E. M., Lenz, H. J., Kelly, K., Villaruz, L. C., Konaté, M. M., Ferry-Galow, K. V., Wang, L., Kinders, R. J., Parchment, R. E., Covey, J. M., Holleran, J. L., Piekarz, R. L., Miller, S. B. & Juwara, L. & 2 others, , Dec 2026, In: Cancer Chemotherapy and Pharmacology. 96, 1, 1.Research output: Contribution to journal › Article › peer-review
Open Access -
Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial
Konstantinopoulos, P. A., Zhou, N., Penson, R. T., Le, T. V., Campos, S., Krasner, C., Wright, A. A., Porter, R., Horowitz, N., Bouberhan, S., Liu, J. F., Hindenach, S., Sawyer, H., Koppermann, L., Hayes, M., Polak, M., Shea, M., Widick, P., Cheng, S. C. & Castro, C. & 3 others, , Dec 2026, In: Nature communications. 17, 1, 395.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemia
Liu, Y., Bollino, D. R., Bah, O. M., Strovel, E. T., Le, T. V., Zarrabi, J., Philip, S., Lapidus, R. G., Baer, M. R., Niyongere, S., Duong, V. H., Dougherty, C. C., Beumer, J. H., Caprinolo, K. D., Kamangar, F. & Emadi, A., Jan 30 2025, In: Blood. 145, 5, p. 486-496 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer
Norton, N., Larson, N. B., Jenkins, G. D., Beumer, J. H., Langevin, B., Gobbaru, J., Morris, M. J., Nakamura, Y., Kroetz, D. L., Zhu, H. J., O'Donnell, P. H., Lewis, L. D. & Hertz, D. L., Dec 2025, In: Clinical and translational science. 18, 12, e70425.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations
Nguyen, M. K., Jelinek, M., Singh, A., Isett, B., Myers, E. S., Mullett, S. J., Eisele, Y., Beumer, J. H., Parise, R. A., Urban, J., Rose, A., Sellitto, L., Singh, K., Doerfler, R., Dadey, R. E., Kim, C., Rhee, J. C., Davar, D., Villaruz, L. C. & Burgess, M. & 8 others, , Nov 1 2025, In: Oncologist. 30, 11, oyaf362.Research output: Contribution to journal › Article › peer-review
Open Access